Lab Head Screening and Assay Automation
High Throughput Biologics, R&D Biologics Research/Protein Therapeutics, Sanofi-Aventis, Germany
Marion Schneider is a biologist with over 20 years of experience in the pharmaceutical industry. She initially worked with small molecules and transitioned to biopharmaceuticals in 2015. Throughout her career, the topics of "Assay" and "Automation" have been a common thread. In recent years, Marion and her team have successfully established an automated high-throughput expression, purification, and screening platform for biologics, enabling the production and analysis of 10 thousand molecules in parallel.
Currently, Marion is leading a screening and assay lab where her focus is on BLI and ELISA technology in the Computational & High-throughput Protein Engineering group.
An Automated Platform for High-Throughput Engineering of Next-Generation Multi-Specific Antibody
Thursday, May 25, 2023
09:30 – 10:15 CET